Anbison Lab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANBISON LAB
ANBISON LAB has four approved drugs.
Summary for Anbison Lab
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Anbison Lab
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 205695-002 | Nov 5, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 205683-001 | Jan 12, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-001 | Sep 30, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-003 | Sep 30, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
